Schuessler Tissue Salts Kali Sulph Skin Balance 7

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Schuessler Tissue Salts Kali Sulph Skin Balance 7
Generic name: KALI SULPHURICUM
Manufacturer: Martin & Pleasance Pty Ltd
Product type: HUMAN OTC DRUG
SPL set ID: 0fa37814-6c70-4834-a0dc-5e729b80f3e5
SPL ID: 395844ca-6baa-db3e-e063-6294a90a7726
Version: 1
Effective date: 2025-07-07
Source export date: 2026-09-28
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:25:11

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Schuessler Tissue Salts Kali Sulph Skin Balance 7	openfda.brand_name
generic name		KALI SULPHURICUM	openfda.generic_name
manufacturer name		Martin & Pleasance Pty Ltd	openfda.manufacturer_name
ndc	package	84999-007-01	openfda.package_ndc
ndc	product	84999-007	openfda.product_ndc
ndc11	package	84999000701	derived:openfda.package_ndc
spl id		395844ca-6baa-db3e-e063-6294a90a7726	id
spl set id		0fa37814-6c70-4834-a0dc-5e729b80f3e5	set_id
unii		1K573LC5TV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Stop use and ask a doctor if • Symptoms persist for more than 7 days or worsen • Inflammation, fever or infection is present or develops • Fever gets worse or lasts more than 3 days If skin eruptions are severe, or painful, seek the advice of a doctor. If pregnant or breastfeeding , ask a health professional before use. Keep out of reach of children .

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.